Scott Requadt - Jul 22, 2022 Form 4 Insider Report for Talaris Therapeutics, Inc. (TALS)

Signature
/s/ Mary Kay Fenton, attorney-in-fact
Stock symbol
TALS
Transactions as of
Jul 22, 2022
Transactions value $
$35,412
Form type
4
Date filed
7/26/2022, 07:38 PM
Previous filing
Nov 1, 2022
Next filing
Jul 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TALS Common Stock Purchase $35.4K +9.44K +2.09% $3.75 461K Jul 22, 2022 Direct F1
holding TALS Common Stock 450K Jul 22, 2022 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.735 to $3.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 These shares are held by Requadt Family Limited Partnership. The Reporting Person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.